Tim Cover & Chiamaka Okoye - VI4 Scientists Doing Things

Professor Tim Cover and graduate student Chiamaka Okoye show off their artistic talents while we asked them some questions about their research...click the image on the left to watch!

Spotlight: Annet Kirabo, DVM, MSc, PhD and Ashley L. Pitzer, PhD

Annet Kirabo, DVM, MSc, PhD, is an Associate Professor of Medicine in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. Dr. Kirabo is interested in understanding the role of inflammation in hypertension. She obtained her PhD from the Department of Physiology and Functional Genomics at the University of Florida College of Medicine. During her PhD training, she was awarded an American Heart Association (AHA) predoctoral fellowship to determine the specific involvement of vascular smooth muscle cell expression of Jak2 in the pathogenesis of cardiovascular disease. Ashley L. Pitzer, PhD, is a Research Instructor in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. She is interested in the molecular mechanisms and genes responsible for cardiac hypertrophy, fibrosis, and hypertension. As a PhD candidate in the Department of Pharmacology and Toxicology at the Virginia Commonwealth School of Medicine, her doctoral dissertation was a molecular study of the mechanism of RIG-I inflammasome in vascular endothelial cell dysfunction....click the image to the left to continue reading!

Spotlight: Tegy J. Vadakkan, Ph.D.

Dr. Tegy Vadakkan received his PhD from the University of Houston, Texas and completed postdoctoral training at Baylor College of Medicine. Before coming to Vanderbilt in January of 2022, Tegy was a lead research technologist at the Boston Children's Hospital at Harvard Medical School... Click the image on the left to continue reading.

Celestine Wanjalla M.D., Ph.D.

Celestine
Wanjalla M.D., Ph.D.
Assistant Professor of Medicine

Dr. Celestine (Celly) Wanjalla is a physician scientist in the Division of Infectious Diseases. She earned her undergraduate degree in Biological Sciences with a distinction in research from Cornell University in Ithaca, and her MD PhD in Immunology and Microbial pathogenesis at Thomas Jefferson University in Philadelphia. She was awarded the Jefferson Graduate School Award in Translational Medicine. She completed residency and fellowship training in Internal Medicine and Infectious Diseases at VUMC. She was awarded a Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research (V-SCHoLARS) K12 award during her postdoctoral training with Dr. John Koethe studying Adipose Tissue T cells and endothelial cell dysfunction in people living with HIV. Her current research seeks to comprehensively define the role of virus-specific immune cells in the pathogenesis of atherosclerotic cardiovascular disease and other diseases of aging. When she is not in the laboratory, she enjoys hiking with her family, trying out new recipes and traveling.

Cardiovascular disease remains the leading cause of death globally despite advancements in the detection and mitigation of risk factors. Though inherently multifactorial, chronic immune activation and inflammation are key mediators of atherosclerotic cardiovascular disease and other comorbidities. Persons living with HIV have twice the risk of developing cardiovascular disease. Persistent exposure to HIV antigens and co-infection with chronic herpes viruses such as CMV or hepatitis B/C contribute to chronic inflammation in PWH and appear to be important in cardiovascular disease pathogenesis.

My lab has adopted a multidisciplinary approach to i) Define virus-specific innate and adaptive immune cells in the peripheral blood and coronary arteries of persons with cardiometabolic disease using existing multiparameter flow cytometry and single-cell techniques. ii) Optimize techniques to better understand the antigenic drivers of the adaptive immune response at the tissue level. Specifically, we design studies that link the viral reservoirs, virus-specific memory T cells, and epitope discovery. iii) Apply/Implement changes in cardiovascular disease risk assessment and therapeutic approaches to improve outcomes in patients.

Major research questions:

  • What is the role of chronic herpes and other viral infections in the pathogenesis of CVD? Do viral antigens expressed in coronary plaques contribute to residual cardiovascular risk?
  • Is there synergy between viral antigens and lipids in the stimulation of adaptive immune cells within coronary plaque? Does this modify the viral epitopes?
  • Can we reduce the burden of residual CVD risk and improve clinical outcomes by targeting viral reservoirs and/or anti-viral cells of the immune system?

Publications on PubMed.gov

celestine.wanjalla@vumc.org

Virus-specific immune responses, chronic inflammation and aging

Monkeypox – what do we know about the virus, and how can we treat the disease?

Monkeypox – what do we know about the virus, and how can we treat the disease? The monkeypox virus has been studied, and its mechanism of replicating and invading human cells are understood. Due to prior research on orthopoxviruses, there is a test currently available for diagnosing monkeypox. Additionally, antiviral therapies are currently under investigation. Finally, a monkeypox vaccine is approved and available for individuals at high risk for contracting the virus. While monkeypox treatment options continue to be studied, a variety of medical resources currently exist for high-risk individuals as well as those who were recently exposed to monkeypox.

Denis Mogilenko, PhD

Denis
Mogilenko, PhD
Assistant Professor of Medicine
Assistant Professor of Pathology, Microbiology, and Immunology
  • PhD: Institute for Experimental Medicine, Saint Petersburg, Russia
  • Postdoctoral Fellow: French Institute of Health and Medical Research (INSERM)
  • Postdoctoral Fellow: Washington University School of Medicine in St. Louis

Our research focuses on how obesity and aging reshape immune responses and lead to inflammatory diseases. Immune cells are sensitive to their metabolic environment, which affects intracellular metabolism and signaling and fine-tune immune functions. We are interested in understanding how metabolic cues regulate communication between immune cells, focusing on dendritic cells and T cells. Our Lab studies how obesity and aging disturb the immune and metabolic balance and lead to excessive inflammation, including diseases such as psoriasis and asthma. We decode molecular mechanisms that link dendritic cell metabolism to tissue inflammation by combining mouse models of inflammatory skin and lung diseases with systems immunology approaches.

Publications on PubMed.gov


Select Publications:

Mogilenko DA*, Shchukina I*, Artyomov MN. Immune ageing at single-cell resolution. Nat Rev Immunol 22, 484–498 (2022). https://doi.org/10.1038/s41577-021-00646-4 (*co-first authors)

Mogilenko DA, Shpynov O, Andhey PS, Arthur L, Swain A, Esaulova E, Brioschi S, Shchukina I, Kerndl M, Bambouskova M, Yao Z, Laha A, Zaitsev K, Burdess S, Gillfilan S, Stewart SA, Colonna M, Artyomov MN. Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8 T cells as conserved hallmark of inflammaging. Immunity 54(1):99-115.e12 (2021). https://doi.org/10.1016/j.immuni.2020.11.005

Brioschi S*, Wang W-L*, Peng V*, Wang M, Shchukina I, Greenberg ZJ, Bando JK, Jaeger N, Czepielewski RS, Swain A, Mogilenko DA, Beatty WL, Bayguinov P, Fitzpatrick JAJ, Schuettpelz LG, Fronick CC, Smirnov I, Kipnis J, Shapiro VS, Wu GF, Gilfillan S, Cella M, Artyomov MN, Kleinstein SH, Colonna M. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science 373(6553):eabf9277 (2021). https://www.science.org/doi/10.1126/science.abf9277 (*co-first authors)

Arthur L*, Esaulova E*, Mogilenko DA, Tsurinov P, Burdess S, Laha A, Presti R, Goetz B, Watson MA, Goss CW, Gurnett CA, Mudd PA, Beers C, O’Halloran JA & Artyomov MN. Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging. Nature Aging 1, 535-549 (2021). https://doi.org/10.1038/s43587-021-00067-x (*co-first authors)

Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K, Swain A, Hayes S, Sheldon RD, Kim H, Kapadnis U, Ellis AE, Isaguirre C, Burdess S, Laha A, Amarasinghe GK, Chubukov V, Roddy TP, Diamond MS; Jones RJ, Simons DM, Artyomov MN. Itaconate confers tolerance to late inflammasome activation. Cell Reports 34(10):108756 (2021). https://doi.org/10.1016/j.celrep.2021.108756

Mogilenko DA, Haas JT, L'homme L, Fleury S, Quemener S, Levavasseur M, Becquart C, Wartelle J, Bogomolova A, Pineau L, Molendi-Coste O, Lancel S, Dehondt H, Gheeraert C, Melchior A, Dewas C, Nikitin A, Pic S, Rabhi N, Annicotte JS, Oyadomari S, Velasco-Hernandez T, Cammenga J, Foretz M, Viollet B, Vukovic M, Villacreces A, Kranc K, Carmeliet P, Marot G, Boulter A, Tavernier S, Berod L, Longhi MP, Paget C, Janssens S, Staumont-Sallé D, Aksoy E, Staels B, Dombrowicz D. Metabolic and innate immune cues merge into a specific inflammatory response via the UPR. Cell 177(5):1201-1216 (2019). https://doi.org/10.1016/j.cell.2019.03.018

Haas JT*, Vonghia L*, Mogilenko DA*, Verrijken A, Molendi-Coste O, Fleury S, Deprince A, Nikitin A, Woitrain E, Ducrocq-Geoffroy L, Pic S, Derudas B, Dehondt H, Gheeraert C, Van Gaal L, Driessen A, Lefebvre P, Staels B, Francque S, Dombrowicz D. Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution. Nature Metabolism 1(6):604-614 (2019). https://doi.org/10.1038/s42255-019-0076-1 (*co-first authors)

Devos M*, Mogilenko DA*, Fleury S, Gilbert B, Becquart C, Quemener S, Dehondt H, Tougaard P, Staels B, Bachert C, Vandenabeele P, Van Loo G, Staumont-Salle D, Declercq W, Dombrowicz D. Keratinocyte expression of A20/TNFAIP3 controls skin inflammation associated with atopic dermatitis and psoriasis. J Invest Dermatol 139(1):135-145 (2019). https://doi.org/10.1016/j.jid.2018.06.191 (*co-first authors)

denis.mogilenko@vumc.org

Immunometabolism in obesity and aging

Monkeypox – symptoms, transmission, and prevention

Monkeypox – symptoms, transmission, and prevention. Since the 1970s, there has been a steady rise in monkeypox virus cases. While the Orthopoxvirus genus is no stranger to the United States, the specific virus responsible for the monkeypox outbreak has largely been found in African countries, until recently. The geographic footprint of the virus and age of those contracting the disease has steadily expanded. While the epidemiology and symptoms associated with monkeypox are complex, the Centers for Disease Control (CDC) and World Health Organization (WHO) have multiple resources to educate us on the disease progression and modes of transmission.